Diagnosis, staging and treatment of hepatocellular carcinoma

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 11, 2004, Pages 1689-1705

  Franca A V C ^a   Junior, J Elias ^a   Lima, B L G ^a   Martinelli, A L C ^a   Carrilho, F J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Barcelona classification; Carcinoma therapy; Hepatocellular carcinoma; Liver cirrhosis; Tumor diagnosis; Tumor staging

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CANCER GROWTH FACTOR; CISPLATIN; DECARBOXYPROTHROMBIN; DOXORUBICIN; EPIRUBICIN; INTERLEUKIN 2; IODINATED POPPYSEED OIL; MITOMYCIN; TUMOR MARKER;

ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; RADIOFREQUENCY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

EID: 9344268301     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004001100015     Document Type: Article

References (60)

1. Bosch FX, Ribes J & Borras J (1999). Epidemiology of primary liver cancer. Seminars in Liver Disease, 19: 271-285.
2. Okuda K (1997). Epidemiology. In: Livraghi T, Makuushi M & Buscarini L (Editors), Diagnosis and Treatment of Hepatocellular Carcinoma. GMM, London, UK.
3. Lescano M, Carneiro M, Elias Junior J, Martinelli A & França A (2002). Experiencia inicial en la evaluación de pacientes with carcinoma hepatocelular em um Hospital terciario. Gastroenterología y Hepatología, 25 (Suppl 2): I-9-I-43.
4. Carrilho FJ (1993). Carcinoma hepatocelular e cirrose hepática. Estudo caso-controle de variáveis clí nicas, bioquímicas, sorológicas e histológicas. Doctoral thesis, Departamento cle Gastroenterologia, Universidade de São Paulo, São Paulo, SP, Brazil.
5. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y & Ohnishi K (1985). Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer, 56: 918-928.
6. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W & Mazziotti A (1992). Natural history of small hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology, 16: 132-137.
7. Sheu JC, Sung JL, Chen DS et al. (1985). Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer, 56: 660-666.
8. Ebara M, Ohto M & Kondo F (1989). Strategy for early diagnosis of hepatocellular carcinoma (HCC). Annals of the Academy of Medicine, Singapore, 18: 83-89.
9. Solmi L, Primerano AMM & Gandolfi L (1996). Ultrasound follow-up of patients at risk for hepatocellular carcinoma. Results of a prospective study on 360 cases. American Journal of Gastroenterology 91: 1189-1194.
10. Bizollon T, Rode A, Bancel B, Gueripel V, Ducerf C, Bauliex J & Trepo C (1998). Diagnostic value and tolerance of lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers. Journal of Hepatology, 28: 491-496.
11. Dodd III, Miller WJ, Baron RL, Skolnick ML & Campbell WL (1992). Detection of malignant tumors in end-stage cirrhotic livers. Efficacy of sonography as a screening technique. American Journal of Roentgenology, 159: 727-733.
12. França AVC (1997). Carcinoma hepatocelular e transplants hepático. Valor dos métodos de imagem no diagnó stico e estadiamento tumoral e na sobrevida de 58 pacientes. Doctoral thesis, Departamento de Gastroenterologia, Universidade de São Paulo, São Paulo, SP, Brazil.
13. Tanaka K, Numata K, Okazaki H, Nakamura S, Inoue S & Takamura Y (1993). Diagnosis of portal vein thrombosis in patients with hepatocellular carcinoma. Efficacy of color Doppler sonography compared with angiography. American Journal of Roentgenology, 160: 1279-1283.
14. Vilana R, Bru C, Bruix J, Castells A, Solé M & Rodes J (1993). Fine-needle aspiration biopsy of portal vein thrombus. Value in detecting malignant thrombosis. American Journal of Roentgenology, 160: 1285-1287.
15. Llovet JM & Beaugrand M (2003). Hepatocellular carcinoma: present status and future prospects. Journal of Hepatology, 38 (Suppl): I-136-I-149.
16. Nomura F, Ohnishi K & Tanabe Y (1989). Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer, 64: 1700-1707.
17. The Cancer of the Liver Italian Program (CLIP) Investigators (1998). A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology, 28: 751-755.
18. The Cancer of the Liver Italian Program (CLIP) Investigators (2000). Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840-845.
19. Ikeda K, Saitoh S, Koida I, Tsubota A, Arase Y, Chayama K & Kumada H (1994). Imaging diagnosis of small hepatocellular carcinoma. Hepatology, 20: 82-87.
20. Ohashi O, Hanafusa K & Yoshida T (1993). Small hepatocellular carcinomas. Two-phase dynamic incremental CT in detection and evaluation. Radiology, 189: 851-855.
21. Rummeny E, Weissleder R, Stark DD, Saini S, Compton CC, Bennett W, Hahn PF, Wittenberg J, Malt RA & Ferrucci JT (1989). Primary liver tumors. Diagnosis by MR imaging. American Journal of Roentgenology, 152: 63-72.
22. Ebara M, Ohto M, Watanabe Y et al. (1986). Diagnosis of small hepatocellular carcinoma. Correlation of MR imaging and tumor histology studies. Radiology, 159: 371-377.
23. Shimamoto K, Sakuma S, Ishigaki T, Ishiguchi T, Itoh S & Fukatsu H (1992). Hepatocellular carcinoma. Evaluation with color Doppler US and MR imaging. Radiology, 182: 149-153.
24. Takayasu K, Shima Y, Muramatsu Y et al. (1986). Angiography of small hepatocellular carcinoma. Analysis of 105 resected tumors. American Journal of Roentgenology, 147: 525-529.
25. Sumida M, Ohto M, Ebara M, Kimura K, Okuda K & Hirroka N (1986). Accuracy of angiography in the diagnosis of small hepatocellular carcinoma. American Journal of Roentgenology, 147: 531-536.
26. Llovet JM, Bruix J, Fuster J et al. (1998). Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology, 27: 1572-1577.
27. França A, Giordano H, Trevisan M, Escanhoela C, Seva-Pereira T, Zucoloto S, Martinelli A & Scares E (2003). Fine needle aspiration biopsy improves the diagnostic accuracy of cut needle biopsy of focal liver lesions. Acta Cytologica, 47: 332-336.
28. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M & Rodés J (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. Journal of Hepatology, 35: 421-430.
29. Llovet JM, Bru C & Bruix J (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Seminars in Liver Disease, 19: 329-338.
30. Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D & Morrow M (2002). AJCC Cancer Staging Handbook. 6th edn. Springer-Verlag, New York, 145-153.
31. Chevret S, Trinchet J-C, Mathieu D, Rached AA, Beaugrand M & Chastang C (1999). A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Journal of Hepatology, 31: 133-141.
32. Leung TWT, Tang AMY, Zee B, Lau WY, Lai PBS, Leung KL, Lau JT, Yu SC & Johnson PJ (2002). Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system. Cancer, 94: 1760-1769.
33. França AVC, Martinelli ALC, Castro e Silva O & Grupo Integrado de Transplante de Fígado do Hospital das Clí nicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (2004). Brain metastasis of hepatocellular carcinoma detected after liver transplantation. Arquivos de Gastroenterologia (in press).
34. Arii S, Yamaoka Y, Kutagawa S, Inoue K, Kobayashi K, Kojiro M, Makuushi M, Nakamura Y, Okita K & Yamada R (2000). Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. Hepatology, 32: 1224-1229.
35. Fong Y, Sun RL, Jarnagin W & Blumgat LH (1999). An analysis of 412 cases of hepatocellular carcinoma at a Western center. Annals of Surgery, 229: 790-799.
36. Llovet JM, Fuster J & Bruix J (1999). Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology, 30: 1434-1440.
37. Yamamoto J, Okada S, Shimada K, Okusata T, Yamasaki S, Ueno H & Kosuge T (2001). Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology, 34: 707-713.
38. Fuster J, García-Valdecasas JC, Grande L et al. (1996). Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Annals of Surgery, 233: 297-302.
39. Bruix J & Llovet JM (2002). Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology, 35: 519-524.
40. Michel J, Suc B, Fourtanier G, Durand D, Rumeau JL, Rostaing L & Lloveras JJ (1995). Recurrence of hepatocellular carcinoma in cirrhotic patients after liver resection or transplantation. Transplantation Proceedings, 27: 1798-1800.
41. Figueras J, Jaurrieta E, Valls C et al. (1997). Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology, 25: 1485-1489.
42. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, Settmacher U & Neuhaus P (2001). Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology, 33: 1080-1086.
43. Mazzaferro V, Regalla E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A & Gennari L (1996). Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. New England Journal of Medicine, 334: 693-699.
44. Yao FY, Ferrel L, Bass NM, Watson JJ, Bachetti P, Venook A, Ascher NL & Roberts JP (2001). Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 33: 1394-1403.
45. Lohmann R, Bechstein WO, Langrehr JM, Knoop M, Lobeck H, Keck H, Lemmems HP, Blumhardt G & Neuhaus P (1995). Analysis of the risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation. Transplantation Proceedings, 27: 1245-1246.
46. Vennok AP, Ferrel LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL & Lake JR (1995). Liver transplantation for hepatocellular carcinoma. Results with preoperative chemoembolization. Liver Transplantation and Surgery, 1: 242-248.
47. França AVC, Lescano MAL & Martinelli ALC (2002). Tratamiento combinado coadyuvante pare el carcinoma hepatocelular previo al trasplante hepático. Gastroenterología y Hepatología, 25: 153-155.
48. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, Torzilli G &The Italian Cooperative HCC Study Group (1995). No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Journal of Hepatology, 22: 522-526.
49. Vilana R, Bruix J, Bru C, Ayuso C, Solé M & Rodés J (1992). Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology, 16: 353-357.
50. Livraghi T, Giorgio A, Marin G et al. (1995). Hepatocellular carcinoma and cirrhosis in 746 patients. Long-term results of percutaneous ethanol injection. Radiology, 197: 101-108.
51. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L & Gazelle GS (1999). Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology, 210: 655-661.
52. Buscarini E, Di Stasi M, Vallisa D, Quaretti P & Rocca A (2001). Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. European Radiology, 11: 914-921.
53. Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, Millena M, Lanocita R & Mazzaferro V (1994). Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology, 192: 687-690.
54. Llovet JM, Real M, Montaña X et al. (2002). Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet, 359: 1734-1739.
55. Groupe D'etude et de Traitment du Carcinome Hepatocellulaire (1995). A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. New England Journal of Medicine, 332: 1256-1261.
56. Castells A, Bruix J, Ayuso C, Bru C, Montanyà X, Boix L & Rodés J (1995). Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. Journal of Hepatology, 22: 410-415.
57. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Odobe Y, Suou T & Kawasaki H (2001). Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma. A randomized control study. Cancer, 92: 1516-1524.
58. Boix L, Bruix J, Castells A, Vianney A, Llovet JM, Rivera F & Rodés J (1996). Circulating mRNA for alpha-fetoprotein in patients with hepatocellular carcinoma. Evidence of tumor dissemination after transarterial embolization. Hepatology, 24: 349A (Abstract).
59. Miller AB, Hoosgstraten B, Staquet M & Winkler A (1981). Reporting results of cancer treatment. Cancer, 47: 207-214.
60. Chow PK, Tao BC, Tan CK, Machin D, Win KM, Johnson PJ & Soo KC (2002). High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized controlled trial. Hepatology, 36: 1221-1226.